The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future Oncology, 2010 - Future Medicine
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future Oncology, 2010 - go.gale.com
Lung cancer is the leading cause of cancer-related deaths worldwide. In 2004, lung cancer
was the eighth most frequent cause of death, causing the deaths of an estimated 1.3 million …
was the eighth most frequent cause of death, causing the deaths of an estimated 1.3 million …
The SATURN Trial: The Value of Maintenance Erlotinib in Patients with Non-Small-Cell Lung Cancer
JW Neal - Future Oncology, 2010 - Taylor & Francis
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future Oncology, 2010 - cir.nii.ac.jp
抄録< jats: p> The first-line treatment of advanced non-small-cell lung cancer (NSCLC)
generally consists of a maximum of six cycles of platinum-based doublet chemotherapy …
generally consists of a maximum of six cycles of platinum-based doublet chemotherapy …
[HTML][HTML] The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future oncology (London, England), 2010 - ncbi.nlm.nih.gov
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future Oncology, 2010 - search.proquest.com
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer.
JW Neal - Future Oncology (London, England), 2010 - europepmc.org
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future oncology (London, England), 2010 - pubmed.ncbi.nlm.nih.gov
The first-line treatment of advanced non-small-cell lung cancer (NSCLC) generally consists
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
of a maximum of six cycles of platinum-based doublet chemotherapy followed by …
[引用][C] The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
JW Neal - Future oncology (London, England) - cochranelibrary.com